The global antiinfective medicine market in 2023 showcased diverse trends across countries. The United Kingdom led with significant sales, reflecting strong demand and growth at 2.8% YoY. South Korea saw a slight decline, while Japan experienced the largest drop. Greece and Slovakia demonstrated the highest growth, with 3.17% and 3.46% YoY, respectively. Notable increases occurred in Iceland and Estonia, suggesting emerging markets. Meanwhile, Belgium and Chile saw moderate growth, whereas Portugal, Austria, and Ireland experienced declines. Over the past five years, regional variances in CAGR indicate shifting dynamics, with select countries in Europe and Latin America outpacing others.
Future trends to watch include the expansion of personalized medicine, increased use of generic antiinfectives, and the impact of regulatory changes on market dynamics. Rising antibiotic resistance and innovations in drug delivery are expected to drive market shifts. Key markets in Asia, particularly Japan and South Korea, may rebound with enhanced R&D investments. Latin American countries like Chile could see growth potential with increased healthcare spending.
Top countries in Antiinfective Medicine Sales by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United Kingdom | 4,440 | 2023 | +2.63% | +2.8% | View data |
| 2 | 2 South Korea | 3,490 | 2023 | +1.36% | -0.33% | View data |
| 3 | 3 Spain | 3,090 | 2023 | +3.45% | +0.88% | View data |
| 4 | 4 Greece | 1,420 | 2023 | +1.9% | +3.17% | View data |
| 5 | 5 Japan | 1,040 | 2023 | -5.06% | -2.99% | View data |
| 6 | 6 Chile | 951.3 | 2023 | +6.46% | +1.41% | View data |
| 7 | 7 Belgium | 939 | 2023 | -1.13% | +2.41% | View data |
| 8 | 8 Sweden | 467.6 | 2023 | +14.36% | -1.79% | View data |
| 9 | 9 Denmark | 315.5 | 2023 | +1.77% | +2.04% | View data |
| 10 | 10 Austria | 291.7 | 2023 | +3.48% | -2.04% | View data |
